Stack of newspapers on a computer keyboard.

In the News

Contract Pharma (January 2020)

Capacity management within functional service partnerships

Tim King and Brian Ford discuss the concept of moving capacity management from sponsors to their FSP vendors.

Contract Pharma
Outsourcing-Pharma (December 2019)

PPD acquires unit, expands neurology capabilities for elderly patients

PPD adds clinical research unit with ‘strong’ recruiting track record to its portfolio, enabling studies on patient populations ‘more reflective’ of the products’ end-users.

Outsourcing-Pharma
DDNews (December 2019)

Special report on liver disease: The phantom menace

Dawie Wessels of AES comments on the cause and treatment of non-alcoholic steatohepatitis (NASH).

ddn news logo
PM360 (December 2019)

PM360 2019 innovative service: SiteCoach from PPD

A shortage of high-quality sites are available for sponsors for certain indications and parts of the world. PPD recognized this obstacle and sought out to address this need.

pm360 logo
Pharmaceutical Outsourcing (December 2019)

The evolving data-driven strategic feasibility model

How democratization of data is powering a new wave of opportunities.

pharmaceutical outsourcing logo
Greater Wilmington Business Journal (December 2019)

PPD adds clinical research site in Florida

Wilmington-based PPD now has a 52-bed clinical research unit in Orlando, Florida, with a focus on early phase trials on neurological disorders.

greater wilmington business journal logo
PharmTech (December 2019)

Meeting E&L expectations

PPD’s Derek Wood discusses the critical importance of extractables and leachables (E&L) evaluations related to drug product safety, efficacy and quality.

pharmtech logo
FierceBiotech (November 2019)

PPD launches ‘SiteCoach’ to help newcomers in clinical trials

PPD has launched a new service aimed at clinical research training for doctors and healthcare workers at new sites to help them stay the course.

fierce biotech logo
PharmaVOICE (November 2019)

Patient care: Treatment to cure

Moving the industry from a focus on treatment to a focus on prevention will require data, new financial incentives, and a change in how healthcare is delivered and paid for.

PharmaVoice logo